Jennerex Biotherapeutics Gets $21.6M
San Francisco-based Jennerex Biotherapeutics has raised $21.6M in funding, the firm announced Thursday. Source of the private placement was not disclosed. Jennerex is developing oncolytic immunotherapies for solid tumors. The company said the funds will be used to advance the clinical development of its lead product candidate.
posted on Friday, May 24, 2013 (Link to more information)
Related companies:
Jennerex
Related stories:
> Jennerex Raises $5M
> Jennerex Raises $8.3M
> Jennerex Closes $5.5M Series C
> Juvaris BioTherapeutics Finds $25M
> CODA Therapeutics Raises $19M
silicontap.com Home